NeoPredics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 7

NeoPredics General Information

Description

Developer of a predictive analytics platform designed to translate medical data into intelligent predictions to support and optimize clinical decisions. The company's platform supports maternal and neonatal applications to evaluate, optimize, and personalize medical strategies for the care of newborns, enabling medical practitioners to improve and personalize health care in early life and avoid long-term complications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Franz-Mayer-Strasse 1
  • 93053 Regensburg
  • Germany
+49 0941
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Franz-Mayer-Strasse 1
  • 93053 Regensburg
  • Germany
+49 0941

NeoPredics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeoPredics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 08-Dec-2025 Completed Generating Revenue
6. Accelerator/Incubator 28-Jul-2023 Completed Generating Revenue
5. Later Stage VC (Series B) Completed Generating Revenue
4. Early Stage VC 12-Sep-2024 Completed Generating Revenue
3. Early Stage VC (Series A2) Cancelled Generating Revenue
2. Early Stage VC (Series A) 15-Mar-2021 $4.5M $4.5M Completed Generating Revenue
1. University Spin-Out 01-Jan-2020 Completed Generating Revenue
To view NeoPredics’s complete valuation and funding history, request access »

NeoPredics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Category A Preferred
To view NeoPredics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

NeoPredics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a predictive analytics platform designed to translate medical data into intelligent predictions to support
Decision/Risk Analysis
Regensburg, Germany
11 As of 2026

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NeoPredics Competitors (1)

One of NeoPredics’s competitors is Sime Diagnostics, a Venture Capital-Backed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sime Diagnostics Venture Capital-Backed London, United Kingdom
You’re viewing 1 of 1 competitors. Get the full list »

NeoPredics Patents

NeoPredics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024056396-A1 Method and system for data processing and report generation Inactive 14-Sep-2022
EP-4540837-A1 Preeclampsia evolution prediction, method and system Pending 21-Jun-2022
US-20230411010-A1 Preeclampsia evolution prediction, method and system Inactive 21-Jun-2022
US-20250132039-A1 Preeclampsia evolution prediction, method and system Pending 21-Jun-2022
WO-2023247308-A1 Preeclampsia evolution prediction, method and system Inactive 21-Jun-2022 G16H50/20
To view NeoPredics’s complete patent history, request access »

NeoPredics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeoPredics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
STARTPLATZ Accelerator/Incubator
Springhood Venture Capital Minority
Mayo Clinic Platform Accelerator/Incubator
Bayern Kapital Venture Capital Minority
Eckenstein-Geigy-Stiftung Not-For-Profit Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

NeoPredics FAQs

  • When was NeoPredics founded?

    NeoPredics was founded in 2020.

  • Where is NeoPredics headquartered?

    NeoPredics is headquartered in Regensburg, Germany.

  • What is the size of NeoPredics?

    NeoPredics has 11 total employees.

  • What industry is NeoPredics in?

    NeoPredics’s primary industry is Decision/Risk Analysis.

  • Is NeoPredics a private or public company?

    NeoPredics is a Private company.

  • What is NeoPredics’s current revenue?

    The current revenue for NeoPredics is .

  • How much funding has NeoPredics raised over time?

    NeoPredics has raised $11.5M.

  • Who are NeoPredics’s investors?

    STARTPLATZ, Springhood, Mayo Clinic Platform, Bayern Kapital, and Eckenstein-Geigy-Stiftung are 5 of 7 investors who have invested in NeoPredics.

  • Who are NeoPredics’s competitors?

    Sime Diagnostics is a competitor of NeoPredics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process